Eledon Pharmaceuticals (ELDN) Depreciation & Amortization (CF) (2013 - 2020)
Eledon Pharmaceuticals posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q3 2020, down 66.67% year-on-year from $3000.0 in Q4 2019, and down 50.0% on a QoQ basis from $2000.0 in Q2 2020.
Eledon Pharmaceuticals (ELDN) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q3 2020.
- For the quarter ending Q3 2020, Depreciation & Amortization (CF) fell 66.67% year-over-year to $1000.0; the trailing twelve-month figure through Jun 2021 stood at $1000.0 (down 88.89% YoY), and the FY2020 full-year result was $5000.0, down 44.44% from the prior year.
- Depreciation & Amortization (CF) for Q3 2020 stood at $1000.0, down from $2000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $53000.0 in Q1 2016 and bottomed at -$4000.0 in Q3 2016.
- The 5-year median for Depreciation & Amortization (CF) is $3000.0 (2018), against an average of $8789.5.
- Peak annual rise in Depreciation & Amortization (CF) reached 960.0% in 2016, while the deepest fall reached 112.5% in 2016.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $19000.0 in 2016, then sank by 78.95% to $4000.0 in 2017, then decreased by 25.0% to $3000.0 in 2018, then tumbled by 33.33% to $2000.0 in 2019, then sank by 50.0% to $1000.0 in 2020.
- The last three Depreciation & Amortization (CF) figures came in at $1000.0 (Q3 2020), $2000.0 (Q2 2020), and $2000.0 (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 4,000.00 |
| Dec 31, 2017 | 4,000.00 |
| Sep 30, 2017 | 2,000.00 |
| Sep 30, 2017 | 2,000.00 |
| Jun 30, 2017 | 12,000.00 |
| Jun 30, 2017 | 12,000.00 |
| Mar 31, 2017 | 4,000.00 |
| Mar 31, 2017 | 4,000.00 |
| Dec 31, 2016 | 19,000.00 |
| Dec 31, 2016 | 19,000.00 |
| Sep 30, 2016 | -4,000.00 |
| Sep 30, 2016 | -4,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Mar 31, 2015 | 5,000.00 |
| Mar 31, 2015 | 5,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Dec 31, 2013 | 3,000.00 |